Detalhe da pesquisa
1.
Essential thrombocytosis: diagnosis, differential diagnosis, complications and treatment considerations of relevance for a cardiologist.
Neth Heart J
; 31(10): 371-378, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36757576
2.
Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A.
bioRxiv
; 2023 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38106192
3.
European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response.
Blood Cancer J
; 12(1): 7, 2022 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35039473
4.
Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia.
J Exp Med
; 171(2): 559-64, 1990 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2106002
5.
A critical reappraisal of treatment response criteria in systemic mastocytosis and a proposal for revisions.
Eur J Haematol
; 84(5): 371-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20059531
6.
Effective management of accelerated phase myelofibrosis with low-dose splenic radiotherapy.
Am J Hematol
; 85(9): 715-6, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20661915
7.
Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.
Leukemia
; 21(9): 1960-3, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17597810
8.
Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients.
Leukemia
; 21(2): 270-6, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17170720
9.
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations.
Leukemia
; 21(8): 1658-68, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17541402
10.
The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1.
Leukemia
; 21(7): 1395-404, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17495975
11.
A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia.
Leukemia
; 21(9): 1964-70, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17581608
12.
The third International Congress on Myeloproliferative and Myelodysplastic Syndromes.
Leuk Res
; 31(1): 11-7, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16620972
13.
'Idiopathic' eosinophilia with an Occult T-cell clone: prevalence and clinical course.
Leuk Res
; 31(5): 691-4, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17095087
14.
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis.
Leuk Res
; 31(11): 1503-9, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17397921
15.
Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid metaplasia.
Leukemia
; 20(10): 1800-8, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16871275
16.
JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.
Leukemia
; 20(6): 971-8, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16598306
17.
Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.
Leukemia
; 20(1): 29-34, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16281063
18.
Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations.
Blood Cancer J
; 7(3): e538, 2017 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28282034
19.
Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients.
Blood Cancer J
; 7(12): 662, 2017 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29282357
20.
Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients.
Blood Cancer J
; 7(3): e550, 2017 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28362440